Prostate clinical trials

Explore recruiting prostate clinical trials.

Recruiting prostate studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Prostate trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ECETEP : Pilot study evaluating PSMA positron emission tomography for monitoring clinically significant prostate cancer after focal HIFU treatment

France

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Subjects With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Chemotherapy

Italy, Greece, France, Belgium, Spain, Sweden +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

SUrGery with or without dARolutamide in high-risk and/or locally advanced prostate cancer

France

Therapeutic exploratory (Phase II) EU CTIS Study details

PEACE 6 Vulnerable : A double-blind randomised phase III trial evaluating the efficacy of ADT +/- darolutamide in de novo metastatic prostate cancer patients with vulnerable functional ability and not elected for docetaxel or androgen receptor targeted agents.

France, Spain, Ireland, Belgium, Italy, Romania +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

HERTHENA-PanTumor01: A Phase 2, Multicenter, Multicohort, Open-Label, Proof of Concept Study of Patritumab Deruxtecan (HER3-DXd) in Subjects with Locally Advanced or Metastatic Solid Tumors

Belgium, France, Spain, Germany, Hungary, Italy +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-641)

Austria, Italy, Netherlands, Germany, Hungary, Ireland +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prostate trials by city

Prostate in Toronto Prostate in Vancouver Prostate in Montreal Prostate in Calgary Prostate in Edmonton Prostate in Ottawa Prostate in Winnipeg Prostate in Quebec City Prostate in Hamilton Prostate in Kitchener Prostate in London Prostate in Halifax Prostate in New York Prostate in Los Angeles Prostate in Chicago Prostate in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease